Rheumatoid arthritis

L-shaped association between serum 25-hydroxyvitamin D and all-cause mortality of individuals with rheumatoid arthritis

Rheumatology (Oxford)Published Prospective cohort study

Main finding · All-cause mortalityResult — go to the resultHazard ratio 0.95 CI 0.92–0.98

Authors' conclusion

An L-shaped association between serum 25-hydroxyvitamin D and all-cause mortality was found among patients with RA

Study context

Population
Patients with RA from National Health and Nutrition Examination Survey (NHANES) 2001–14 (mean age 59.89 years; 58.94% female)
Participants
1,466 patients10,453 person-years
Exposure
Higher vs lower serum 25-hydroxyvitamin D
Outcome
All-cause mortality (National Death Index death certificate records)
Methodological detailsNHANES 2001-14, Cox proportional hazards models, generalized additive model, smooth curve fitting, 2-piecewise Cox proportional hazards models
  • NHANES 2001-14
  • Cox proportional hazards models
  • Generalized additive model, smooth curve fitting
  • 2-piecewise Cox proportional hazards models

Main finding

All-cause mortality

Hazard ratio

0.95

CI 0.92–0.98

P < 0.01

Higher 25-hydroxyvitamin Dvs <25.00 nmol/l
HR 0.95 (CI 0.92–0.98); P < 0.01

As reported in the abstract

All-cause deaths
268

Observational data: associations, not effects.

Further findings

Cause-specific deaths

CVD deaths
52
Cancer deaths
48

Serum 25-hydroxyvitamin D level

Weighted mean 25-hydroxyvitamin D (SD), nmol/l
59.26 (24.99)
Deficient or severe deficient vitamin D (<50.00 nmol/l)
38.95%

Original publication

L-shaped association between serum 25-hydroxyvitamin D and all-cause mortality of individuals with rheumatoid arthritis. Rheumatology (Oxford). Published 11 June 2022. doi:10.1093/rheumatology/keac341

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.